Regeneron Pharmaceuticals reported $20.69B in Equity Capital and Reserves for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Agenus AGEN:US $ 3.42M 12.3M
Agios Pharmaceuticals AGIO:US $ 1124.07M 83.38M
Alimera Sciences ALIM:US $ -12.34M 3.73M
Alnylam Pharmaceuticals ALNY:US $ 176.04M 225.13M
Amgen AMGN:US $ 2419M 1503M
Astellas Pharma 4503:JP Y 1539052M 78744M
AstraZeneca AZN:LN 2951310.75M 184237.79M
Biogen BIIB:US $ 11872.5M 630.2M
Biomarin Pharmaceutical BMRN:US $ 4504.81M 113.49M
Bluebird Bio BLUE:US $ 180.12M 83.14M
Bristol Myers Squibb BMY:US $ 32600M 1020M
Eli Lilly And LLY:US $ 8544.7M 786.1M
Esperion Therapeutics ESPR:US $ -291698000 42.66M
Gilead Sciences GILD:US $ 20215M 288M
GlaxoSmithKline GSK:LN 1637400M 19300M
Intercept Pharmaceuticals ICPT:US $ -369.83M 1.93M
IONIS PHARMACEUT IONS:US $ 624.73M 84.85M
Kyowa Hakko Kirin 4151:JP Y 765460M 21007M
Moderna Inc MRNA:US 17.98B 910M
Neurocrine Biosciences NBIX:US $ 1423.4M 32.3M
Novartis NOVN:VX SF 62925M 1385M
Novartis NVS:US $ 62925M 1385M
Ophthotech OPHT:US $ 292.95M 40.21M
Opthea Ltd OPT:AU 138.12M 2.83M
Puma Biotechnology PBYI:US $ 19.74M 12.59M
Regeneron Pharmaceuticals REGN:US $ 20687.8M 773.1M
Sarepta Therapeutics SRPT:US $ 726.46M 130.43M
Seattle Genetics SGEN:US $ 2932.81M 65.66M
Teva Pharmaceutical TEVA:IT 9.04B 307M
Ultragenyx Pharmaceutical RARE:US $ 678.07M 118.35M
United Therapeutics UTHR:US $ 4318.4M 142.1M
Vertex Pharmaceuticals VRTX:US $ 11933.5M 1026.5M
YTE INCY:US $ 4085.06M 221.99M